GLP-1 Medications: The Real Reason We're Seeing More Adverse Events

Introduction

You may have seen recent reports suggesting a dramatic rise in adverse events and overdoses related to GLP-1 medications such as semaglutide and tirzepatide. Some headlines describe increases of over 1,000%. That number gets attention—but it requires context.

Reported GLP-1 exposures by month (2025 YTD). Source: U.S. Poison Control Centers.

What the Data Shows

Reported exposures have increased—but these reflect calls and reports, not necessarily severe toxicity.

GLP-1 exposure reports over time. Source: U.S. Poison Control Centers.

Over the past several years, reported exposures have risen alongside the rapid expansion in use. This pattern suggests that the increase is not simply about the medication itself—but how widely and variably it is being used.

Increasingly, GLP-1 medications are being used outside of structured medical supervision.

What Has Changed

Historically, these medications were prescribed within structured care:

• Careful dose escalation

• Ongoing monitoring

Active management of side effects

• Today, many patients are using these medications with:

• Minimal supervision

• Limited follow-up

• Little guidance on dosing or side effects

This shift matters.

Why This Matters Clinically

GLP-1 medications act on the pancreas, brain, and stomach to regulate metabolism, appetite, and digestion.

GLP-1 therapies:

• Increase insulin

• Decrease glucagon

• Suppress appetite

• Slow gastric emptying

These are not minor effects. They influence multiple physiologic systems at once.

Without proper guidance, patients may:

• Undereat significantly

• Become dehydrated

• Lose lean muscle

• Misinterpret expected vs. concerning symptoms

What Proper Care Looks Like

Effective GLP-1 therapy requires guidance, monitoring, and ongoing adjustment.

Appropriate use of GLP-1 therapy includes:

• Structured dose escalation

• Monitoring of tolerance and response

• Nutritional guidance—especially protein intake

• Hydration support

• Attention to muscle preservation

This is not excessive care. It is appropriate care.

The Bottom Line

GLP-1 medications can be highly effective. But they are being used far too casually. The rise in adverse events is not simply because more people are using them. It is because too many people are using them without proper medical guidance.